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Editorial on the Research Topic
Roles of Sleep Disruption and Circadian Rhythm Alterations on Neurodegeneration and
Alzheimer’s Disease
Striking changes in circadian rhythms, including the sleep-wake rhythm, characterize many
neurodegenerative processes, e.g., Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s
disease, and traumatic brain injury (TBI). Because disturbances in circadian rhythm and sleep can
precede the overt cognitive impairment, they have been postulated as risk factors or predictors of
these diseases (Musiek and Holtzman, 2016).
Circadian rhythms represent biological adaptations to dramatic and predictable daily changes
in the physical environment experienced by virtually all organisms living on earth. By definition,
circadian rhythms have an intrinsic period length of∼24 h, are endogenously generated (i.e., persist
under constant environmental conditions), are temperature compensated (i.e., the period is little
affected by temperature) and can be entrained by temporal cues (zeitgebers). Although the light-
dark cycle is the most robust zeitgeber, other factors including activity and timing of food can
modify circadian phase. Circadian rhythms govern the rhythmic expression of a large portion of the
genome (Zhang et al., 2014) and a wide range of cellular, physiological, and behavioral processes,
including the daily sleep-wake rhythm.
Sleep is regulated not only by the circadian phase but also by the time elapsed since prior sleep
(the homeostatic sleep drive), according to the two-process model of sleep regulation (Borbély,
1982). Although these processes were initially considered to be independent, they have since
been shown to influence each other. Sleep deprivation can alter the phase of circadian rhythms
(Antle and Mistlberger, 2000) and the expression of circadian clock genes (Franken et al., 2007).
Destruction of the suprachiasmatic nucleus (SCN), the master mammalian circadian pacemaker,
not only ablates the daily sleep-wake rhythm but also increases the total amount of sleep in
squirrel monkeys (Edgar et al., 1993) and non-REM sleep in mice (Easton et al., 2004). Thus, loss
of sleep affects the timing of circadian rhythms while circadian rhythm alterations impair sleep,
underscoring a complex relationship between these processes (Mistlberger, 2005; Morin, 2013;
Scammell et al., 2017).
Neural circuits regulating sleep and circadian rhythm output are vulnerable to brain damage
and neurodegeneration (Coogan et al., 2013; Theofilas et al., 2017). For example, accumulation
of amyloid-beta disrupts circadian rhythms and sleep (Tate et al., 1992; Roh et al., 2012). On
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the other hand, disruption of circadian rhythms or sleep
deleteriously affects many physiological, behavioral, and
neuronal functions (Musiek and Holtzman, 2016; Zhu et al.,
2016). Current evidence suggests that the bi-directional
interactions between neurodegeneration and disruption of
circadian rhythms and sleep exacerbates neuropathology in AD
and other neurological disorders (Wang and Holtzman, 2020). In
this special issue, discrete circadian rhythm alterations in these
disorders and their associations with specific neuropathological
processes are described in articles by Fifel and Videnovic and
Green et al.
Sleep disruptions appear prior to the prodromal stages of
AD, and include fragmentation of the daily sleep-wake rhythm,
reduced total sleep, and loss of deep sleep (i.e., slow wave
sleep) (Tranah et al., 2011; Guarnieri et al., 2012; Lim et al.,
2013; Guarnieri and Sorbi, 2015). Two articles in this issue
focus on AD-related changes in discrete neuronal oscillations.
As Mander describes, AD neuropathology is accompanied by
deficits in three types of local sleep oscillations: (1) frequency-
specific frontal slow-wave expression during non-REM sleep,
(2) parietal sleep spindles expression, and (3) the quality
of electroencephalographic desynchrony in REM sleep. The
association of these specific sleep deficits with amyloid-beta
and tau pathology and their potential roles in sleep-dependent
memory processes and cognitive changes in AD are discussed.
The mechanistic importance of AD-associated deficits in slow
wave activity is emphasized in the article by Lee et al.,
which reviews studies showing that the frequency of slow
waves affects memory consolidation, amyloid deposition, and
neuronal calcium homeostasis. Slow wave sleep is proposed as a
therapeutic target for AD.
Variations in neuronal oscillatory activity also occur in
patients with moderate obstructive sleep apnea (OSA), a
common breathing disorder associated with brain injury and
memory impairment. As described by Zhou et al. in this
issue, dynamic changes in EEG spectral power occur during
respiratory events, including cortical hyperactivation during
N2 sleep, suppression of β-band information transmission,
abnormal interhemispheric effective connectivity, and
intrahemispheric “rise-to-down” fluctuations in the γ band.
This work provides insights into how OSA affects cognition and
neuropsychiatric function.
To enable preclinical investigations of therapeutic strategies
to ameliorate sleep and circadian dysfunction in AD, animal
models that temporally replicate these disturbances and
neurodegeneration are needed. While some AD mouse models
exhibit changes in sleep and circadian rhythms resembling those
seen in AD patients, these changes are not consistent across
the models, as described by Sheehan and Musiek in this issue.
This review provides a fine-grained analysis of the expression of
circadian rhythms reported from various models and provides
suggestions on how to standardize and optimize future studies of
circadian rhythms in AD mouse models. Also in this issue, Lippi
et al. describe daily activity rhythms and their responses to zinc
in a novel mouse model that exhibits amyloid and tau pathology
based on a cross between the J20 (hAPP) and P301L (Tau)
lines. Sare et al. report on the TgF344-AD rat model of AD that
expresses age-dependent tau and amyloid pathology. Age-related
changes in rest-activity rhythms, cognitive performance, and
hyposmia are exhibited by the TgF344-AD rats with interesting
sex-dependent effects.
Several article in this issue described basic research focused on
the underlying mechanisms linking sleep and circadian rhythm
dysfunction to neurodegeneration. Sharma et al. review this
topic with a special focus on the effect of aberrant circadian
rhythmicity on E3 ligase and poly adenosine disphophate (ADP-
ribose) polymerase 1 activity in Parkinson’s disease. Cassar et al.
developed a knock-in Drosophila model of tauopathy and reveal
that mutant tau disrupts daily sleep rhythms independent of
circadian rhythm changes by interfering with central pacemaker
neuron output connectivity. Green et al. describe the role of sleep
disruption-associated inflammation in mediating the increased
risk of AD occurring with traumatic brain injury. Todd focuses
on the potential neural pathways by which circadian rhythm
disruption may cause the aggression and agitation that AD
patients exhibit during “sundowning syndrome.”
Together, the articles presented in this special issue highlight
important questions to address regarding interactions between
sleep, circadian rhythms, and neurodegeneration and describe
newer models and approaches that may facilitate this work.
Overall, the work substantiates the concept that study of neural
consequences of circadian and sleep disturbances will provide
insight into molecular bases of neurodegenerative processes,
while study of sleep and circadian rhythms in animal models
and humans with neurodegeneration will provide fundamental
knowledge of sleep and circadian neurobiology. These efforts
will meet with the greatest success when experts in all three
fields collaborate.
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